Zobrazeno 1 - 2
of 2
pro vyhledávání: '"E. Grobost-Dalbin"'
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 11:e285
Background Clinical scores of thrombo-embolism risk (CHA2DS2-VASc) and hemorrhagic risk (HAS-BLED) have been developed to characterize the patients with non-valvular atrial fibrillation. These scores have been defined in part with clinical risk facto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d06d1f2b72a5df2e59d9f2c29e0ef0d
https://doi.org/10.1016/j.acvdsp.2019.01.007
https://doi.org/10.1016/j.acvdsp.2019.01.007
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 11:17
Background Clinical scores of thromboembolism risk (CHA2DS2-VASc) and hemorrhagic risk (HAS-BLED) have been developed to characterize the patients with non-valvular atrial fibrillation. These scores have been defined in part with clinical risk factor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f2dffebb31e1bfc9bf0cb1090527d73
https://doi.org/10.1016/j.acvdsp.2018.10.031
https://doi.org/10.1016/j.acvdsp.2018.10.031